GSK

Graphic of a dart right on a bullseye sun breaking through the clouds in the background
Biotech

GSK’s itch prospect hits mark in phase 3 liver disease trial

The win keeps the drugmaker on track to launch the first treatment for the relentless itching experienced by some liver disease patients.
Nick Paul Taylor Nov 19, 2024 8:24am
psych neuro brain

GSK pays Flagship biotech $80M for preclinical neuro pact

Nov 12, 2024 6:30am
pivot change turnaround direction walk away

GSK axes vaccine from $2.1B deal, switches to preclinical heir

Oct 30, 2024 7:06am
Photo of a final puzzle piece about to fit into a puzzle

GSK aims to extend lupus dominance via $300M T-cell engager deal

Oct 29, 2024 8:00am
doctor handshake

GSK and Cambridge scientists join forces in $65M immune R&D deal

Oct 22, 2024 3:30pm
Pulmonologist showing CT scan of lungs woman patient being examined in the background

GSK and Boston scientists team up to tackle lung diseases

Oct 18, 2024 11:26am